Literature DB >> 3190505

Pulmonary function and dysfunction in multiple sclerosis.

S C Smeltzer1, M J Utell, R A Rudick, R M Herndon.   

Abstract

Pulmonary function was studied in 25 patients with clinically definite multiple sclerosis with a range of motor impairment. Forced vital capacity (FVC), maximal voluntary ventilation (MVV), and maximal expiratory pressure (MEP) were normal in the ambulatory patients (mean greater than or equal to 80% predicted) but reduced in bedridden patients (mean, 38.5%, 31.6%, and 36.3% predicted; FCV, MVV, and MEP, respectively) and wheelchair-bound patients with upper extremity involvement (mean, 69.4%, 50.4%, and 62.6% predicted; FVC, MVV, and MEP, respectively). Forced vital capacity, MVV, and MEP correlated with Kurtzke Expanded Disability Status scores (tau = -0.72, -0.70, and -0.65) and expiratory muscle weakness occurred most frequently. These findings demonstrate that marked expiratory weakness develops in severely paraparetic patients with multiple sclerosis and the weakness increases as the upper extremities become increasingly involved.

Entities:  

Mesh:

Year:  1988        PMID: 3190505     DOI: 10.1001/archneur.1988.00520350083020

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Reversible central neurogenic hyperventilation in an awake patient with multiple sclerosis.

Authors:  M Takahashi; T Tsunemi; T Miyayosi; H Mizusawa
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

2.  Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough.

Authors:  Toni Chiara; A Daniel Martin; Paul W Davenport; Donald C Bolser
Journal:  Arch Phys Med Rehabil       Date:  2006-04       Impact factor: 3.966

3.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

4.  Hypoxemia during oral feedings in adults with dysphagia and severe neurological disabilities.

Authors:  B Rogers; M Msall; D Shucard
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 5.  Respiratory muscle training for multiple sclerosis.

Authors:  Marc B Rietberg; Janne M Veerbeek; Rik Gosselink; Gert Kwakkel; Erwin Eh van Wegen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-21

Review 6.  Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Authors:  Benedikt Schoser; Edward Fong; Tarekegn Geberhiwot; Derralynn Hughes; John T Kissel; Shyam C Madathil; David Orlikowski; Michael I Polkey; Mark Roberts; Harm A W M Tiddens; Peter Young
Journal:  Orphanet J Rare Dis       Date:  2017-03-16       Impact factor: 4.123

7.  Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple Sclerosis.

Authors:  Elisabeth Westerdahl; Martin Gunnarsson; Anna Wittrin; Ylva Nilsagård
Journal:  Mult Scler Int       Date:  2021-06-14

8.  Lung volume recruitment in multiple sclerosis.

Authors:  Nadim Srour; Carole LeBlanc; Judy King; Douglas A McKim
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.